
    
      At the discretion of the Investigator, 10-30 mg of oral domperidone is administered QID (four
      times a day). The Investigator will be starting patients on 10 mg four times a day for 2
      weeks, then increase to 20 mg four times a day for 2 weeks. The participant will be evaluated
      at each time point. If the participant still is not having relief of symptoms the
      investigator may increase their dose to 30mg four times a day.
    
  